Healthcare is no longer just a public good — it’s a measurable investment frontier.
According to J.P. Morgan’s Guide to Alternatives® (2025), healthcare consistently ranks among the top five private-equity sectors, driven by demographic shifts, digital transformation, and sustained Merger & Acquisition activity.
GLOHBX extends this evolution to emerging markets by linking health outcomes to yield through C4 AI verification, diaspora co-financing, and blended-guarantee mechanisms.
The result: verifiable, outcome-linked returns that redefine healthcare as a resilient, low-correlation asset class for investors and governments alike.
